Apisense: EIC Accelerator Bet on Sensing Sick Bee Colonies

The standard way to find American foulbrood, Nosema or Varroa in a colony is to open the hive and look, a method the company's EU project calls slow, labour-intensive and often ineffective. Apisense, a Kraków company registered in 2022, says it can catch those diseases earlier with a sensor that sits in the brood nest and reads the colony's chemical and acoustic signals, combined with satellite and weather data in an AI model. The project's own figure for the stakes: up to 36% of Europe's honeybee colonies are lost each year.

The project, S.A.F.E., appears in the EIC Accelerator's March 2025 cut-off for blended finance. CORDIS records a grant agreement signed on 6 October 2025 with an EU contribution of €2,487,827.96, running from 1 January 2026 to 31 December 2027, a figure the EIC's own company page repeats. Ten months into the project, the hardware is on sale; the accuracy the company claims for it has not been published.

A company that is selling, and still in its first project

The National Court Register shows Apisense as an active limited company with a four-person management board, its latest entry dated 3 September 2026, and amended articles of association notarised on 22 June 2026. Its main registered activity is research and development in the natural and technical sciences, with electronics manufacturing and software among the others. The register sections for arrears, receivership and liquidation are empty. Annual accounts have been filed for every year from 2022 to 2025, the last on 9 July 2026; their figures were not accessible for this article.

The company's online shop lists a VitalSensor at 449 zł, a HiveScale at 849 zł and a Pro AI Starter Pack (three sensors, a scale and a solar hub) at 2,999 zł. No subscription price is shown, although a banner advertises an offer tied to the Polish agricultural payments agency ARiMR, which runs EU-funded support schemes for beekeepers, bundling a sensor with 12 months of subscription. The Apisense app, published by Apisense sp. z o.o., lists a version 1.0 from April 2025 and had reached version 2.7.0 by late October 2026, with too few ratings for the store to display a score.

Reading the colony instead of opening it

Hive monitors are not new. The Irish company ApisProtect, for example, fixed a sensor under the hive roof that tracked temperature, movement, humidity and sound, as the Irish Farmers Journal described it in 2021. Apisense's claim is that it also reads the colony's chemistry. Its product explainer describes the VitalSensor as sitting in the brood nest around the clock and collecting chemical, bioacoustic and behavioural signals, and calls pheromones "a key channel" of information about the queen, the colony's state and threats. Its Bee Health Intelligence page lists pheromone-related signals, in-hive sound, weight and temperature, inspection photos and satellite-derived forage data as inputs, and Varroa, Nosema and foulbrood as the target diseases.

The only scientific trace of the chemical approach found for this article is a poster at the APIMONDIA congress in Copenhagen in September 2025, recorded in the bibliography of AGH University of Kraków under the title "Apisense: AI-enhanced sensors for detecting bee pheromones and VOCs to monitor colony health and predict Varroa, Nosema, and Foulbrood Infestations". The AGH record lists seven authors, including Sebastian Cibor, Bartosz Kądziołka and Michał Wierzbiński, with Apisense as an affiliation of two of them; a second record lists the same title in the congress abstract book. Neither record shows the abstract or any results. The company's blog also lists an IAC 2026 paper on mapping bee forage from satellite data and a nine-day acoustic pilot with 13 prototypes in a blueberry field, both on pollination rather than disease.

What S.A.F.E. promised

The CORDIS objective describes "a non-invasive method that integrates IoT multimodal sensors, an AI-driven engine, and satellite imagery" for real-time monitoring and prediction of bee pathogens. The business case in the same text is ambitious: an addressable market the company puts at €9.4 billion by 2030, based on 101 million beehives worldwide; a 5% share of it through device sales plus a monthly analytics subscription; colony losses cut by up to 80%; operating costs cut "by a factor of 23"; and more than €78 million of accumulated revenue by 2031. These are the company's targets, not results the EIC has verified. CORDIS gives no total project cost and shows no report yet, which is normal for a project that started in January 2026.

The EIC impact page carries a progress account in the company's terms: the VitalSensor finalised in the first quarter of 2026 with more than 2,000 units manufactured for large-scale validation, over 200 cooperation agreements signed worldwide, PCT patent applications and trademarks filed, and the team enlarged; extended field trials in the second quarter, with AI models "validated for Varroa, Nosema, and AFB"; and pre-commercial deployments planned for the third quarter of 2026. The page does not say where the trials ran, how many colonies took part or what the validation found.

1. In-hive sensor ready for productionOn saleVitalSensor priced at 449 zł in the company shop; 2,000+ units made, per the EIC page.
2. Software and subscription serviceApp liveApp at version 2.7.0 in Apple's store; no subscription price published.
3. 95% disease detection accuracyNot publishedClaimed on the website and in CORDIS; no study or test data found.
4. Validation for Varroa, Nosema and AFBCompany statementReported on the EIC page with no trial sites, colony numbers or results.
5. 80% fewer colony losses, 5% market shareToo earlyTargets for the period after the project ends in December 2027.

How many hives

Apisense publishes several measures of its reach, and they do not line up. The home page claims more than 350 installations in more than 40 countries on six continents and more than 300 members of a partnership programme. The product explainer says more than 400 apiaries use the technology, monitoring nearly 3,000 hives in over 40 countries. The EIC page counts more than 2,000 sensors manufactured. The figures measure different things and may all be true at once, but none is broken down into paying customers, and the logos on the home page (universities, the Polish Beekeepers Association, an Emirati beekeepers' foundation) are not described as customers.

The money

The EIC grant is the only funding for Apisense that a primary source documents. Data aggregators disagree on the rest: VCBacked lists a seed round in June 2025 of undisclosed size with the EIC Accelerator as the investor, and Caplight lists grants from the European Innovation Council, an accelerator round with 28Digital in March 2023 and a total of $118,000 raised, without amounts per round. Neither names a private equity investor, and no press release announcing a round could be found. The award was blended finance, which allows for an EIC Fund equity stake next to the grant; the EIC's company page lists only the EU contribution, and no EIC Fund investment in Apisense has been announced.

Why the EU funds bee monitoring

In January 2023 the Commission revised its pollinators strategy as "A new deal for pollinators" (COM(2023) 35), which, as VLAIO's EU monitor summarised the Commission's announcement, aims to "reverse the decline of pollinators by 2030". That strategy is mainly about wild insects, while Apisense sells to keepers of managed honeybees, but CORDIS tags 40% of the S.A.F.E. budget to biodiversity, as it does to climate, digital and AI goals. The narrower case in the project itself is fewer chemical treatments and fewer lost colonies, and Apisense also markets a second product line, Pollination Intelligence, that measures pollination in crop fields. Apisense is not the first beehive company selected by the EIC Accelerator, which also picked 3Bee, Beewise and Vatorex.

Apisense has not been asked for comment for this article. The reporting is based on publicly available sources, listed below.